(Q53516190)

15 May 2018

title

Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. (English)

1 reference

15 May 2018

main subject

cervix uterine cancer

1 reference

4

1 reference

15 May 2018

June-Key Chung

7

object named as

June-Key Chung

1 reference

15 May 2018

author name string

Hyun Hoon Chung

1

1 reference

15 May 2018

Hoenil Jo

2

1 reference

15 May 2018

Won Jun Kang

3

1 reference

15 May 2018

Noh-Hyun Park

5

1 reference

15 May 2018

Yong-Sang Song

6

1 reference

15 May 2018

Soon-Beom Kang

8

1 reference

15 May 2018

Hyo-Pyo Lee

9

1 reference

15 May 2018

language of work or name

English

0 references

publication date

16 October 2006

1 reference

15 May 2018

published in

Gynecologic Oncology

1 reference

15 May 2018

volume

104

1 reference

15 May 2018

issue

3

1 reference

15 May 2018

page(s)

529-534

1 reference

15 May 2018

Estimating the world cancer burden: Globocan 2000.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Recurrent cervical carcinoma after radical hysterectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Posttherapy surveillance monitoring of cervical cancer by FDG-PET.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

The role of PET scanning in the detection of recurrent cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Positron emission tomography for unexplained elevation of serum squamous cell carcinoma antigen levels during follow-up for patients with cervical malignancies: a phase II study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Surgical management of locally recurrent rectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Is carcino-embryonic antigen useful in the follow-up management of patients with colorectal liver metastases?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Second-look operation for recurrent colorectal cancer based on carcinoembryonic antigen and imaging techniques

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy- D-glucose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Prognostic value of positron emission tomography (PET) with fluorine-18 fluorodeoxyglucose ([18F]FDG) after first-line chemotherapy in non-Hodgkin's lymphoma: is [18F]FDG-PET a valid alternative to conventional diagnostic methods?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Histologic grade and lymph node metastasis in squamous cell carcinoma of the cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Clinical role of FDG PET in evaluation of cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Body CT and oncologic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Benign causes of 18-FDG uptake on whole body imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

F-18 fluorodeoxyglucose chest uptake in lung inflammation and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

Factors associated with false-positive staging of lung cancer by positron emission tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.09.009

10.1016/J.YGYNO.2006.09.009

7 January 2021

Identifiers

DOI

1 reference

15 May 2018

1 reference

15 May 2018